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Test-Request Patterns for Clinical Chemistry in a British and a Canadian Renal Dialysis Unit Mary D. Gardner1 and A. Ralph Henderson2
We recorded, during four months, the total number of routine clinical chemistry tests requested for patients with end-stage renal failure who were on regular maintenance hemodialysis during the study: 20 in the Renal Dialysis Unit of a British and 20 in a Canadian teaching hospital. The pattern of tests ordered was substantially the same in each unit, but the frequency of testing was not. The total number of tests (and tests per patient per month) was 1616 (20.2) for the British and 6939 (86.7) for the Canadian unit (significant at p < 0.001). This study suggests a significant difference between the two countries in the utilization of laboratory services, and supports our earlier findings on total clinical chemical workloads in hospitals.
AdditIonal Keyphrases: laboratory test utilization nomios of laboratory operation
We previously showed that Canadian clinicians request up to eight times as many tests as do their British counterparts (1,2). Because the patient mix in each country and in each hospital was not entirely similar, however, we decided to compare the requesting patterns from a more circumscribed group of patients. Treatment of patients undergoing regular hemodialysis for end-stage renal failure is unlikely to vary significantly in different countries, and we have compared the clinical chemistry test workload in Glasgow Royal Infirmary (GRI) and in University Hospital (UH), London, Canada, by comparing the tests requested by the Renal Dialysis Units in each hospital. Both are teaching hospitals in the tertiary-care category as defined by Mechanic (3).
Materials and Methods
We monitored the number of individual tests done on each patient during four months (April through July, 1981 hospital were dialyzed regularly all during this four-month period; similar dialysis schedules were used in each Unit. Both Units sent "routine bloods" to the laboratory for the tests listed in Table 1 , according to a set protocol established by the physicians in each Renal Unit. Funding for these protocols arises from the operating budget of each hospital and is not influenced by, or subject to, any external agency. At GRI the physician can order from a menu of tests on the Request Form; at UH, entire profiles or individual constituent tests of that proffle can be ordered on the Request Form (4). The methodologies in use in each hospital have been described (2,4). The requested patterns in GRI and UH were similar, although GRI added determinations of aluminum and parathyrin (which UH subsequently added in 1982), and UH added glucose, y-glutamyltransferase, osmolality, and the isoenzymes of lactate dehydrogenase.
We used the Mann-Whitney U Test to test the significance of the monthly data between hospitals (5).
Results and Discussion
Although the pattern of tests is similar, the frequency of requesting is not. The total number of tests done during the study period was 1616 in GRI and 6939 in UH. This amounts to a mean of 20.2 tests per patient per month (range 15.5-36.3) for GRI and 86.7 (58-178) for UH, a significant difference (p < 0.001). The weekly laboratory workload in UH is roughly equivalent to the monthly workload in GRI.
The expected workload figures are 17-19 tests per patient per month for GRI and 62 for UH. The actual workload is therefore an increase of 12.2% and 39.8%, respectively, over the expected workload. The surveillance of the three diabetic patients in the UH group added an additional 178 glucose estimations. Omitting the glucose tests from the UH test numbers reduces the actual workload at UH to 84.5 tests per patient per month. There were no diabetic patients in GRI Renal Dialysis Unit at the time of this study.
At GRI, priority (UH: "stat") tests account for only a small proportion of the "unexpected" tests. In the four-month period GRI had five priority requests (or 15 tests): two requests for electrolytes, urea, and creatimne (one from each of two patients), and three requests for potassium from a digitalized patient. At UH, there were 542 "stat" tests (i.e., #{176}Measured twice(on 'electrolyte" and"calcium" analyzers). cDedc patients haveglucosemeasured aboutthreetimesweekly. 5Only on patientsreceiving magnesium tnsilicate as a phosphate-binding agent.
tests requested for which the results are required within 2 h of sample receipt by the laboratory), which amounted to 7.8% of the total tests requested (or 6.8 tests per patient per month). Of the "stat" requests, 79% were for serum potassium; on the average, UH patients had 5.4 "stat" requests for potassium per month. At UH it is customary to estimate serum potassium at the beginning of the first dialysis period of the week, so the potassium content of the dialysis fluid can be adjusted-hence the "stat" requests. Also, four. UH patients were being treated with digitalis-type drugs throughout the study period. By contrast, at GRI, priority requests for serum potassium assay were received three times in the four-month period, all on the one patient being treated with digitalis-type drugs. In summary, patients at UH had 36-fold more "stat" requests than the GRI patients, or 28.7-fold more if we do not count the "stat" glucose requests on the three diabetics at UH.
Patients stabilized on regular dialysis treatment and free of new symptoms usually show no abrupt changes in blood chemistry.
However, the longer time on dialysis and the older dialysis population in the UI! unit-which contained higher-risk patients such as the diabetic group-probably create an increment of additional laboratory testing over that generated by the GRI dialysis population. Moreover, some GRI patients are sent to home dialysis or continuous ambulatory peritoneal dialysis after stabilization in the hospital program, and the aim is to do this with as many as possible, although some have been dialyzed for years. At UH, the higher-risk patients are viewed as requiring continuing hospital care. Each unit thus maintains a level of laboratory monitoring that is regarded as providing an acceptable level of patient surveillance while recognizing that blood sampling can be a significant source of blood loss, and thus that laboratory tests should be minimized in Renal Dialysis Units (6). Thus, the fourfold difference in the amount of testing between the two units reflects to some extent the non-uniform populations in the two units. In addition, however, there does appear to be a wide divergence between Canadian and British teaching hospitals as regards levels of laboratory utilization.
Serum creatinine
and potassium, for example, are ordered eightfold more often, per inpatient day, in Canadian hospitals than in British hospitals (1). Both groups use similar types of analytical equipment, which suggests that these utilization differences are not due to limitations of equipment. In another study (2), we showed that a Canadian teaching hospital with 391 acutecare beds performed almost the same (within 20%) number of tests as a British teaching hospital with 1557 acute-care beds and 640 chronic-care beds. In that comparison the very close correspondence in analytical equipment and productivity between the two hospitals again suggested that equipment or staff restraints were not responsible for the lower test utilization in Britain.
However, we believe that we have identified several differences between the countries that, together, may form the basis for the differing utilization. One involved undergraduate education in the medical schools. In Glasgow, medical students have a systematic course of instruction in clinical chemistry. By contrast, at the University of Western Ontario, although there is systematic instruction in (e.g.)
clinical pharmacology and tissue pathology, there is none in clinical chemistry. The Canadian medical student therefore receives less instruction in the utilization of laboratory services.3We (2) also showed, during the year of our survey, that the ability of the department of clinical chemistry to communicate with the clinical services of the hospital (an extremely time-conswmng but essential process) must be much lessin the Canadian hospital (two professional laboratory staff4) than in the British hospital (22 to 28 professional laboratory stafi). Ontario has 14 clinical chemists, as compared with Britain's 28, per million population (2). Thus, on the basis of education and professional consultation in clinical chemistry, the Canadian physician is probably less well served than his counterpart in Britain. Conversations between a physician and a laboratory physician about a test-request for many tests often result in fewer tests being done. Undoubtedly, if this dialogue followed every request, there would be much less work for the laboratory.
Of the factors that Connelly and Steele (7) assume to contribute to problems of laboratory use, the majority are "physician factors." Under the sub-heading "faulty therapeutic monitoring techniques" they include repeating tests too frequently, ordering batteries (when subsets would suffice), automatic repetition of tests, and the use of routine protocol orders, some of which we believe may be responsible for the inappropriate workload in UI! (8). Connelly and Steele also assert that medical education is a key factor in laboratory utilization. Grivell 4By "professional laboratory staff' we mean a clinical chemist who has at least a baccalureate degree (and often a doctorate), several years of training in clinical chemistry, and a professional qualification in the discipline of clinical chemistry awarded by a professional association. A clinical chemist may also possess a medical qualification. We excluded the "resident" (N. America)! "registrar" (U.K.) grade from our figures.
We suggest that, in monitoring renal-dialysis patients, the choice of tests and the frequency of sampling is best described by ongoing discussion between clinicians and professional laboratory personnel: an agreed, and regularly reviewed, protocol understood by both laboratory and clinical staff is in the best interests of both the patient and interdepartmental hospital relations. Significantly, discussion of our findings with University Hospital staff has led to a re-evaluation of ordering practices.
We are grateful for the co-operation of the staff of the Renal Dialysis Units in both hospitals.
